Z999-0009C Screening compound: 3-isobutyl-6-methyl-4-oxo-N~5~-[6-({[2-(1-pyrrolidinyl)ethyl]amino}carbonyl)-3-pyridyl]-3,4-dihydrofuro[2,3-d]pyrimidine-5-carboxamide

Z999-0009C Screening compound: 3-isobutyl-6-methyl-4-oxo-N~5~-[6-({[2-(1-pyrrolidinyl)ethyl]amino}carbonyl)-3-pyridyl]-3,4-dihydrofuro[2,3-d]pyrimidine-5-carboxamide
Z999-0009C Screening compound: 3-isobutyl-6-methyl-4-oxo-N~5~-[6-({[2-(1-pyrrolidinyl)ethyl]amino}carbonyl)-3-pyridyl]-3,4-dihydrofuro[2,3-d]pyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Z999-0009C
3-isobutyl-6-methyl-4-oxo-N~5~-[6-({[2-(1-pyrrolidinyl)ethyl]amino}carbonyl)-3-pyridyl]-3,4-dihydrofuro[2,3-d]pyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Z999-0009C

Molecular Formula

C24H30N6O4 (C24 H30 N6 O4)

Compound Name

3-isobutyl-6-methyl-4-oxo-N~5~-[6-({[2-(1-pyrrolidinyl)ethyl]amino}carbonyl)-3-pyridyl]-3,4-dihydrofuro[2,3-d]pyrimidine-5-carboxamide

IUPAC name

5-[6-methyl-3-(2-methylpropyl)-4-oxo-3H4H-furo[23-d]pyrimidine-5-amido]-N-[2-(pyrrolidin-1-yl)ethyl]pyridine-2-carboxamide

SMILES

CC(C)CN(C=Nc1c2c(C(Nc(cc3)cnc3C(NCCN3CCCC3)=O)=O)c(C)o1)C2=O

InChI

InChI=1S/C24H30N6O4/c1-15(2)13-30-14-27-23-20(24(30)33)19(16(3)34-23)22(32)28-17-6-7-18(26-12-17)21(31)25-8-11-29-9-4-5-10-29/h6-7,12,14-15H,4-5,8-11,13H2,1-3H3,(H,25,31)(H,28,32)

InChI Key

IVKONFMKPHJIFL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27641307

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

466.54

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.790

Distribution Coefficient, logD

0.054

Water Solubility, LogSw

-2.23

Polar Surface Area

94.825

Acid Dissociation Constant (pKa)

8.39

Base Dissociation Constant (pKb)

9.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.83

Z999-0009C in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Z999-0009C chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Z999-0009C?
Check Price and Availability of Z999-0009C, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Z999-0009C you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Z999-0009C
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Z999-0009C
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Z999-0009C available by request